NCT05940870 A Prospective Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention. Status COMPLETED Phase N/A
NCT05893004 German Translation and Cross-cultural Adaptation of the Headache Screening Questionnaire (HSQ) Followed by a Test-retest Reliability Study. Status COMPLETED Phase NA
NCT05861427 Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine Status COMPLETED Phase PHASE3
NCT05854992 Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women Status COMPLETED Phase N/A
NCT05853900 Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Status COMPLETED Phase NA
NCT05842642 Effects of Adding an Oculomotor Therapy Treatment in Patients With Migraine Status COMPLETED Phase NA
NCT05827887 An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants Status COMPLETED Phase N/A
NCT05810038 A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. Status COMPLETED Phase PHASE3
NCT05804396 Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine Status WITHDRAWN Phase NA
NCT05785988 Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS) Status RECRUITING Phase N/A